Having accurate data readily available as new viral outbreaks occur is imperative if we are to learn what steps to take to help control it worldwide. The more informed we are, the better equipped we’ll be to inform the public of the necessary pre-cautions to take to help stem the spread of the virus and ultimately save lives.

In MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market, Harry Glorikian (along with Malorye Allison Branca) show through examples what a new data-driven healthcare system could look like when implemented on a global basis. The authors reveal where data and cutting-edge analytics are already advancing healthcare and creating new and evolving business opportunities.

The book includes interviews with dozens of healthcare leaders, and describes the business challenges and opportunities arising for those working in one of the most vibrant sectors of the world’s economy. The authors map out many of the changes taking place, and describe how they are impacting everyone from patients to researchers to insurers, and outline some predictions for the healthcare industry in the years to come.

MoneyBall Medicine makes a compelling case for embracing technology and the use of data to revolutionize the healthcare system for the greater good of patients and healthcare professionals alike.

Author Harry Glorikian also hosts the MoneyBall Medicine™ Podcast, a series all about the data-driven transformation of the healthcare and life sciences landscape. An influential global business expert with more than three decades of experience building successful ventures in the U.S. and around the world, Glorikian is well known for his achievements in the life sciences, healthcare, diagnostics and healthcare IT industries. He is a sought-after speaker who has addressed the National Institutes of Health, Molecular Medicine Tri-Conference, World Theranostics Congress and other audiences worldwide.

He has written numerous articles for industry publications, appeared on CBS Evening News, and has been quoted regularly by Dow Jones, The Boston Globe, BioWorld Today, Los Angeles Times, London Independent, Medical Device Daily, Science Magazine, Genetic Engineering News and many other media outlets. He is also the author of Commercializing Novel IVD’s: A Comprehensive Manual for Success. 

For more information, please visit www.glorikian.com